Jeong-Jin Seo “Unlimited supply of corona antibody therapy to domestic manufacturing costs… vaccine development”

Input 2021.02.20 10:14

Seo Jeong-jin (Photo) Celltrion Group Honorary Chair Celltrion (068270)In Korea, the company announced that it will provide unlimited supply of the Corona 19 antibody treatment’Recyronaju’ (ingredient name Legdanvimab CT-P59) at the manufacturing cost in Korea.

Honorary Chairman Seo said in an online conversation with Thomas Burn, chairman of the Korea Society, a non-profit organization in the United States on the 19th (local time), It is a business,” and said, “Antibody treatment drugs will be supplied to Korea at an unlimited cost as needed.

At the same time, the honorary chairman said, “We will provide as much as possible to all Koreans and provide the rest to the world and countries in need.

Honorary Chairman Seo said, “We are preparing to develop and produce vaccines if necessary.” He introduced, “So far, only one antibody treatment has been dedicated, but vaccine candidates are also being developed.”

Honorary Chairman Seo said, “Many pharmaceutical companies are participating in combating Corona 19 because of the mutant virus, and we will do our best to help the world get out of the corona 19 crisis.” When it comes to turn, it must be right. There is no drug without side effects,” he emphasized.

In addition, the honorary chairman said that he would contribute to the global drug price reduction through the development of biosimilars (generic biopharmaceuticals), and “We will go until the world uses good drugs that have not been accessible because of the high price.”